8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed May 28, 2026 · 1mo ago · Accession 0001213900-26-062184
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- RELMADA THERAPEUTICS, INC.
- Ticker
- RLMD
- CIK
- 1553643
- Form type
- 8-K
- Filing date
- May 28, 2026
- Report date
- May 27, 2026
- Document
- ea0292521-8k_relmada.htm
- Size
- 2.4 MB